The economic impact of machine perfusion technology in liver transplantation

Introduction Several clinical studies have demonstrated the safety, feasibility, and efficacy of machine perfusion in liver transplantation, although its economic outcomes are still underexplored. This review aimed to examine the costs related to machine perfusion and its associated outcomes. Method...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Artificial organs Jg. 46; H. 2; S. 191 - 200
Hauptverfasser: Boteon, Yuri L., Hessheimer, Amelia J., Brüggenwirth, Isabel M. A., Boteon, Amanda P. C. S., Padilla, María, Meijer, Vincent E., Domínguez‐Gil, Beatriz, Porte, Robert J., Perera, M. Thamara P. R., Martins, Paulo N.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Wiley Subscription Services, Inc 01.02.2022
Schlagworte:
Clinical deterioration
Complications
Cost control
Cost-Benefit Analysis
Costs
cost‐analysis
Depreciation
Economic analysis
Economic impact
health economics
Humans
hypothermic machine perfusion
Impact analysis
Liver
Liver transplantation
Liver Transplantation - economics
Liver Transplantation - methods
Liver transplants
Logistics
machine perfusion of the liver
normothermic machine perfusion
normothermic regional perfusion
Optimization
Perfusion
Perfusion - economics
Perfusion - methods
Tissue and Organ Procurement - economics
Tissue and Organ Procurement - methods
Transplantation
Transplants & implants
machine perfusion of the liver
cost-analysis
normothermic machine perfusion
normothermic regional perfusion
hypothermic machine perfusion
liver transplantation
health economics
ISSN:0160-564X, 1525-1594, 1525-1594
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction Several clinical studies have demonstrated the safety, feasibility, and efficacy of machine perfusion in liver transplantation, although its economic outcomes are still underexplored. This review aimed to examine the costs related to machine perfusion and its associated outcomes. Methods Expert opinion of several groups representing different machine perfusion modalities. Critical analysis of the published literature reporting the economic outcomes of the most used techniques of machine perfusion in liver transplantation (normothermic and hypothermic ex situ machine perfusion and in situ normothermic regional perfusion). Results Machine perfusion costs include disposable components of the perfusion device, perfusate components, personnel and facility fees, and depreciation of the perfusion device or device lease fee. The limited current literature suggests that although this upfront cost varies between perfusion modalities, its use is highly likely to be cost‐effective. Optimization of the donor liver utilization rate, local conditions of transplant programs (long waiting list times and higher MELD scores), a decreased rate of complications, changes in logistics, and length of hospital stay are potential cost savings points that must highlight the expected benefits of this intervention. An additional unaccounted factor is that machine perfusion optimizing donor organ utilization allows patients to be transplanted earlier, avoiding clinical deterioration while on the waiting list and the costs associated with hospital admissions and other required procedures. Conclusion So far, the clinical benefits have guided machine perfusion implementation in liver transplantation. Albeit there is data suggesting the economic benefit of the technique, further investigation of its costs to healthcare systems and society and associated outcomes is needed. Up to now, the clinical benefits have guided machine perfusion implementation in liver transplantation. In this expert opinion of several groups representing different machine perfusion modalities, a critical analysis of the published literature reporting the economic outcomes of the most used techniques of machine perfusion in liver transplantation was performed. The limited current literature suggests that although this upfront cost varies between perfusion modalities, its use is highly likely to be cost‐effective.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0160-564X
1525-1594
1525-1594
DOI:10.1111/aor.14131